A randomized controlled trial recently published in Scientific Reports showed positive effects of a specific hyperbaric oxygen therapy (HBOT) protocol on neurocognitive functions and symptoms among patients with long COVID. These findings suggest HBOT can induce neuroplasticity and improve cognitive, psychiatric, fatigue, sleep and pain symptoms in patients with long COVID.
Recently Coauthor Amir Hadanny, MD, PhD, a neurosurgeon and also the chief medical research officer and head of research at Aviv Clinics, sat down in an interview with NeurologyLive® to discuss how the patients responded to the HBOT protocol. Hadanny also spoke about the 3 main theories surrounding the pathophysiology of long COVID, and how they impact specific areas of the brain. He also talked about how the traditional symptom-focused approach to managing long COVID differs from the innovative HBOT protocol. Hadanny explained what factors determine whether a long COVID patient should undergo 40 or 60 sessions of HBOT, and how the duration of symptoms plays a crucial role with the treatment process.
View full article here: www.neurologylive.com/view/di...